A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib

Figure 1

Magnetic resonance imaging of patient’s brain obtained before and after initiation of ibrutinib. (a) Subependymal enhancement in December 2014 (T1 postcontrast). (b) Periventricular hyperintensity in December 2014 (FLAIR). (c) Leptomeningeal enhancement in December 2014 (postcontrast). (d) Left optic sheath enhancement in January 2015 (postcontrast). (e) Subependymal enhancement resolved in March 2015 (T1 postcontrast). (f) Periventricular hyperintensity resolved in March 2015 (FLAIR). (g) Leptomeningeal enhancement resolved in March 2015 (postcontrast). (h) Left optic sheath enhancement decreased in March 2015 (postcontrast).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)